Striking’ new treatment for deadly prostate cancer could increase life expectancy - The new combination of drugs could increase life expectancy in what researchers called a ‘striking’ finding ...

Men treated for nonmetastatic prostate cancer under current guidelines are up to 6 times less likely to die from their cancer than from other causes, according to data from a Swedish cancer registry.

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

Patients with advanced cancer gained nearly a full year of additional life if they quit smoking, compared to those who kept ...